Resveratrol shows promise in improving glycemic control
by Newsletter Editor
In this resveratrol study, 66 people with type 2 diabetes took a placebo or 1,000 mg of resveratrol per day along with continuing to take standard anti-diabetic treatment. After 45 days, compared to the start of the study, fasting blood sugar levels and LDL, the “bad” cholesterol, increased slightly in the placebo group, while those who took resveratrol saw significantly lower systolic blood pressure, lower fasting and long-term average glucose levels, and less circulating insulin and insulin resistance. Also, HDL, the “good” cholesterol, significantly increased.
Discussing their findings, doctors said some of the decrease in long-term average glucose levels and increases in HDL with resveratrol are very significant and comparable to the benefits from front-line anti-diabetic drugs. Also, 1,000 mg of resveratrol per day for 45 days had no adverse effects, and resveratrol not only complemented standard medication, but increased protection in type 2 diabetes beyond standard therapy, doctors concluded.